Familial Hypercholesterolaemia in the Precision Medicine Era: Epidemiology, Genetics, Risk Stratification, and Therapeutic Innovations. (2025). Diabzen, 3(3), 86-99. https://www.thediabzen.com/index.php/d/article/view/26